๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mitomycin C and vinblastine chemotherapy for advanced breast cancer

โœ Scribed by P. H. Konits; J. Aisner; D. A. Van Echo; K. Lichtenfeld; P. H. Wiernik

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
395 KB
Volume
48
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Secondary chemotherapy of advanced breas
Secondary chemotherapy of advanced breast cancer
โœ Ira S. Goldenberg; C. A. McMahan; George C. Escher; Herbert Volk; Fred J. Ansfie ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 255 KB ๐Ÿ‘ 2 views
Vinblastine, adriamycin, thiotepa, and h
Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy
โœ Marjorie Perloff; Ronald D. Hart; James F. Holland ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 279 KB

Nineteen postmenopausal patients with metastatic breast cancer refractory to conventional combination chemotherapy were treated with monthly cycles with the combination of vinblastine, adriamycin, thiotepa and halotestin. Ten patients (52%) responded with a greater than 50% regression of measurable

Neoadjuvant chemotherapy in locally adva
Neoadjuvant chemotherapy in locally advanced breast cancer
โœ Singh, Gurpreet; Singh, Deepinder P.; Gupta, Devender; Muralikrishna, Bhavaraju ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB ๐Ÿ‘ 1 views

Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were